KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Capital Leases (2020 - 2025)

Nu Skin Enterprises' Capital Leases history spans 6 years, with the latest figure at $6.3 million for Q4 2025.

  • For Q4 2025, Capital Leases fell 23.09% year-over-year to $6.3 million; the TTM value through Dec 2025 reached $6.3 million, down 23.09%, while the annual FY2025 figure was $6.3 million, 23.09% down from the prior year.
  • Capital Leases for Q4 2025 was $6.3 million at Nu Skin Enterprises, down from $8.3 million in the prior quarter.
  • Across five years, Capital Leases topped out at $12.1 million in Q4 2022 and bottomed at $5.3 million in Q4 2021.
  • The 5-year median for Capital Leases is $8.3 million (2024), against an average of $8.3 million.
  • The largest annual shift saw Capital Leases plummeted 31.19% in 2021 before it soared 128.28% in 2022.
  • A 5-year view of Capital Leases shows it stood at $5.3 million in 2021, then skyrocketed by 128.28% to $12.1 million in 2022, then fell by 22.17% to $9.4 million in 2023, then fell by 12.68% to $8.3 million in 2024, then dropped by 23.09% to $6.3 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Capital Leases are $6.3 million (Q4 2025), $8.3 million (Q4 2024), and $9.4 million (Q4 2023).